Clinical Trials Directory

Trials / Completed

CompletedNCT03446937

Effect of Antenatal Corticosteroids on Neonatal Morbidity.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
150 (actual)
Sponsor
Ahmadu Bello University Teaching Hospital · Academic / Other
Sex
Female
Age
18 Years – 49 Years
Healthy volunteers
Accepted

Summary

It will be a randomized controlled trial. There will be two study groups. Study group 1 will be given dexamethasone while study group 2 will be given betamethasone. The control group will be given placebo.

Detailed description

The study will be a double blind randomised controlled trial. There will be two study groups and one control group. The first study group will be the pregnant women at risk of late preterm birth that will receive antenatal corticosteroids in the form of intramuscular dexamethasone sodium phosphate. The second study group will be the pregnant women at risk of late preterm birth that will receive antenatal corticosteroids in the form of intramuscular betamethasone sodium phosphate. The control group will be pregnant women at risk of late preterm birth that will be given intramuscular water for injection.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasone Sodium Phosphate InjectionDexamethasone sodium phosphate injection 12 mg X doses to be given 12 hours apart
DRUGBetamethasone Sodium Phosphate Injection (Medication)betamethasone sodium phosphate injection12mg X 2 doses given 12 hours apart
DRUGWater for injectionTwo doses of intramuscular injection of water for injection given 12 hours apart

Timeline

Start date
2017-12-01
Primary completion
2019-05-31
Completion
2019-05-31
First posted
2018-02-27
Last updated
2019-12-27

Locations

1 site across 1 country: Nigeria

Source: ClinicalTrials.gov record NCT03446937. Inclusion in this directory is not an endorsement.

Effect of Antenatal Corticosteroids on Neonatal Morbidity. (NCT03446937) · Clinical Trials Directory